F. A. Andrew Hack
Affiliations
- at Mersana Therapeutics Inc. (MRSN), 2025-06-13
- at Nuvalent Inc. (NUVL), 2024-12-13
- at Dynavax Technologies Corp (DVAX), 2023-08-10
- Director at Allena Pharmaceuticals Inc. (ALNA), 2020-11-18
- Director at Atea Pharmaceuticals Inc. (AVIR), 2020-11-04
- Chief Financial Officer at Bcls Acquisition Corp. (BLSA), 2020-10-26
- Chief Financial Officer at Editas Medicine Inc. (EDIT), 2019-02-06
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| NUVL | $33.50 | 149,253 | $4,999,975.50 | 3,577,267 | 2022-11-03 | Filing |
| MRSN | $3.20 | 14,760 | $47,181.82 | 8,663,673 | 2022-06-02 | Filing |
| MRSN | $3.28 | 80,759 | $264,776.46 | 8,648,913 | 2022-05-31 | Filing |
| MRSN | $3.19 | 75,000 | $238,942.50 | 8,568,154 | 2022-05-26 | Filing |
| MRSN | $3.18 | 90,155 | $286,242.13 | 8,493,154 | 2022-05-25 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| NUVL | $88.00 | 1,250,000 | $110,000,000.00 | 1,447,267 | 2024-12-11 | Filing |
| NUVL | $72.31 | 791,795 | $57,254,696.45 | 2,697,267 | 2024-03-27 | Filing |
| NUVL | $76.88 | 88,205 | $6,781,262.14 | 3,489,062 | 2024-03-27 | Filing |
| DVAX | $14.39 | 1,500,000 | $21,585,000.00 | 915,000 | 2023-08-08 | Filing |
| DVAX | $12.68 | 500,000 | $6,340,000.00 | 2,415,000 | 2023-06-14 | Filing |